RALA and EXOC2

  • Number of citations of the paper that reports this interaction (PMID 14525976)
  • 66
  • Data Source:
  • HPRD (in vivo, two hybrid, in vitro)

RALA

EXOC2

Gene Name v-ral simian leukemia viral oncogene homolog A (ras related) exocyst complex component 2
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 32 interactors: ARF1 CALM1 CNKSR2 EXOC1 EXOC2 EXOC3 EXOC4 EXOC5 EXOC6B EXOC7 EXOC8 FLNA HRAS LRPAP1 LSM2 PIH1D2 PLCD1 PLD1 PPP2R1B RAB34 RAB8B RALBP1 RALGPS1 RAP1A RAP2A RAP2B RASSF5 REPS1 RGL2 RGL4 SMAD4 YBX3 7 interactors: ESX1 EXOC3 EXOC7 EXOC8 RALA SERGEF VPS53
Entrez ID 5898 55770
HPRD ID 01549 11544
Ensembl ID ENSG00000006451 ENSG00000112685
Uniprot IDs P11233 B2RBE6 Q96KP1
PDB IDs 1UAD 1ZC3 1ZC4 2A78 2A9K 2BOV
Enriched GO Terms of Interacting Partners?
Tagcloud ?
adoptive  antitumor  capability  chimeric  combining  effectors  engineered  fused  genetically  gtp  immunotherapeutic  killer  meaningful  mhc  moieties  ncr1  ncrs  nk  nkp46  partly  proto  ralb  recognition  recognize  regressions  remarkable  retrovirally  termed 
agouti  albinism  asip  atf1  delta25  dopachrome  edn1  edn3  ednrb  exocyst  kitlg  ludwigshafen  mc1r  microphthalmia  oca2  oculocutaneous  pigmentation  prkacb  prkacg  prkar1a  prkar2a  prkar2b  proopiomelanocortin  slc24a4  slc45a2  tautomerase  tpcn2  tubb3  tyrp1 
Tagcloud (Difference) ?
adoptive  antitumor  capability  chimeric  combining  effectors  engineered  fused  genetically  gtp  immunotherapeutic  killer  meaningful  mhc  moieties  ncr1  ncrs  nk  nkp46  partly  proto  ralb  recognition  recognize  regressions  remarkable  retrovirally  termed 
agouti  albinism  asip  atf1  delta25  dopachrome  edn1  edn3  ednrb  exocyst  kitlg  ludwigshafen  mc1r  microphthalmia  oca2  oculocutaneous  pigmentation  prkacb  prkacg  prkar1a  prkar2a  prkar2b  proopiomelanocortin  slc24a4  slc45a2  tautomerase  tpcn2  tubb3  tyrp1 
Tagcloud (Intersection) ?